HUTCHMED (China) Limited
0013Pharmaceuticals
HK$21.16+0.28%As of Oct 29vs prior close
- Market cap
- $2.3B
- P/E (TTM)
- 131.1×
- P/E (FY1)
- 39.0×
- From 52W high
- −16.82%
- EPS (TTM)
- –
- Revenue (LTM)
- $549.1M
- Net margin
- 3.26%
Nomior Score
38
Steady ProfileBottom 25% of the scored universe
Growth64
Quality33
Value32
Momentum43
Resilience46
Growth
+8.76%revenue a year over 3 fiscal years
YE22 $426.4MLTM $549.1M
Connections
Revenue to profitYE25
83% of revenue became net profit, up 77 pts on a year.